A drug evaluation of 1% tenofovir gel and tenofovir disoproxil fumarate tablets for the prevention of HIV infection

Author： Gengiah Tanuja N Baxter Cheryl Mansoor Leila E Kharsany Ayesha BM Abdool Karim Salim. S

ISSN： 1354-3784

Source： Expert Opinion on Investigational Drugs, Vol.21, Iss.5, 2012-05, pp. : 695-715

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Emtricitabine/Tenofovir Disoproxil Fumarate: In Combination with a Protease Inhibitor in HIV-1 Infection

By Perry Caroline M.

Drugs, Vol. 69, Iss. 7, 2009-05 ,pp. : 843-857

Adis International

Access to resources Recommend Favorite

Tenofovir disoproxil fumarate: durable efficacy in heavily pretreated HIV-1 infection

Inpharma, Vol. 1, Iss. 1317, 2001-01 ,pp. : 17-18

Adis International

Access to resources Recommend Favorite

A new drug combination therapy for treatment-naive patients with HIV-1 infection, consisting of raltegravir, emtricitabine and tenofovir disoproxil fumarate

By Clercq Erik De

Expert Opinion on Pharmacotherapy, Vol. 10, Iss. 17, 2009-12 ,pp. : 2935-2937

Informa Healthcare

Access to resources Recommend Favorite

Tenofovir Disoproxil Fumarate: A Review of its Use in the Management of HIV infection

By Lyseng-Williamson Katherine A. Reynolds Neil A. Plosker Greg L.

Drugs, Vol. 65, Iss. 3, 2005-01 ,pp. : 413-432

Adis International

Access to resources Recommend Favorite

Emtricitabine/Rilpivirine/Tenofovir Disoproxil Fumarate Single-Tablet Regimen: A Guide to Its Use in HIV-1 Infection

By Lyseng-Williamson Katherine A. Scott Lesley J.

Clinical Drug Investigation, Vol. 32, Iss. 10, 2012-10 ,pp. : 715-722

Adis International

Access to resources Recommend Favorite